esophageal cancer
Findings from two clinical studies were reported at Digestive Disease Week earlier this month that supported use of the firm's EsoCheck device and EsoGuard test.
Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion
The company hopes to build prospective clinical utility evidence for the Esopredict test, its first clinical assay, to support future reimbursement.
ProPhase Labs Partners With mProbe, Mayo Clinic on Esophageal Cancer Screening Test
The mass spec-based proteomic assay, which was originally developed by Stella Diagnostics, is designed for the early detection of esophageal cancer.
Castle Biosciences Q4 Revenues Jump 53 Percent as Firm Beats Analyst Expectations
Castle also reported full-year revenues at the top end of previously issued guidance and offered full-year 2023 guidance ahead of Wall Street expectations.
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.